A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment
Anavex Life Sciences shares were up 7% to $11.25 after the company said it saw positive trial results for its oral blarcamesine for the treatment of early Alzheimer's disease. The clinical-stage ...
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III ...
Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
The Amazing Times on MSN7 小时
Five Common Medications That May Increase Your Risk of Dementia
Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...
News Medical on MSN8 小时
Spear Bio secures FDA breakthrough device designation for its novel pTau 217 blood test ...
Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.
Medscape9 小时
Updated Alzheimer’s Guidelines Chart the Full Diagnostic Journey
Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...
Daily Independent20 小时
With severe dementia, medications are of limited benefit
The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...